Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Leukemia
>>
RET inhib
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Iclusig
(ponatinib) / Takeda, Otsuka
sorafenib
/ Generic mfg.